Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon 56Fe Ions

Michael M. Weil, Joel S. Bedford, Helle Bielefeldt-Ohmann, F. Andrew Ray, Paula C. Genik, Eugene J. Ehrhart, Christina M. Fallgren, Fitsum Hailu, Christine L.R. Battaglia, Brad Charles, Matthew A. Callan, Robert L. Ullrich

Research output: Contribution to journalArticlepeer-review

89 Scopus citations


Estimates of cancer risks posed to space-flight crews by exposure to high atomic number, high-energy (HZE) ions are subject to considerable uncertainty because epidemiological data do not exist for human populations exposed to similar radiation qualities. We assessed the leukemogenic efficacy of one such HZE species, 1 GeV 56Fe ions, a component of space radiation, in a mouse model for radiation-induced acute myeloid leukemia. CBA/CaJ mice were irradiated with 1 GeV/nucleon 56Fe ions or 137Cs γ rays and followed until they were moribund or to 800 days of age. We found that 1 GeV/nucleon 56Fe ions do not appear to be substantially more effective than γ rays for the induction of acute myeloid leukemia (AML). However, 56Fe-ion-irradiated mice had a much higher incidence of hepatocellular carcinoma (HCC) than γ-irradiated mice, with an estimated RBE of approximately 50. These data suggest a difference in the effects of HZE iron ions on the induction of leukemia compared to solid tumors, suggesting potentially different mechanisms of tumorigenesis.

Original languageEnglish (US)
Pages (from-to)213-219
Number of pages7
JournalRadiation research
Issue number2
StatePublished - Aug 1 2009

ASJC Scopus subject areas

  • Biophysics
  • Radiation
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon <sup>56</sup>Fe Ions'. Together they form a unique fingerprint.

Cite this